- Home
- TXMD vs USEA Comparison
TXMD vs USEA Comparison
Compare TXMD & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- USEA
- Stock Information
- Founded
- TXMD 2008
- USEA 2004
- Country
- TXMD United States
- USEA Greece
- Employees
- TXMD N/A
- USEA N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- TXMD Health Care
- USEA Consumer Discretionary
- Exchange
- TXMD Nasdaq
- USEA Nasdaq
- Market Cap
- TXMD 12.3M
- USEA 15.6M
- IPO Year
- TXMD N/A
- USEA N/A
- Fundamental
- Price
- TXMD $1.03
- USEA $1.67
- Analyst Decision
- TXMD
- USEA
- Analyst Count
- TXMD 0
- USEA 0
- Target Price
- TXMD N/A
- USEA N/A
- AVG Volume (30 Days)
- TXMD 16.9K
- USEA 21.3K
- Earning Date
- TXMD 11-11-2025
- USEA 11-25-2025
- Dividend Yield
- TXMD N/A
- USEA 2.38%
- EPS Growth
- TXMD N/A
- USEA N/A
- EPS
- TXMD N/A
- USEA N/A
- Revenue
- TXMD $2,559,000.00
- USEA $42,625,000.00
- Revenue This Year
- TXMD $427.09
- USEA N/A
- Revenue Next Year
- TXMD N/A
- USEA N/A
- P/E Ratio
- TXMD N/A
- USEA N/A
- Revenue Growth
- TXMD 156.93
- USEA N/A
- 52 Week Low
- TXMD $0.70
- USEA $1.00
- 52 Week High
- TXMD $2.44
- USEA $2.53
- Technical
- Relative Strength Index (RSI)
- TXMD 39.61
- USEA 47.40
- Support Level
- TXMD $0.99
- USEA $1.61
- Resistance Level
- TXMD $1.09
- USEA $1.75
- Average True Range (ATR)
- TXMD 0.03
- USEA 0.06
- MACD
- TXMD -0.00
- USEA -0.01
- Stochastic Oscillator
- TXMD 41.24
- USEA 32.77
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of seven dry bulk vessels, comprising three Panamax, two Capesize and two Kamsarmax vessels with an aggregate cargo-carrying capacity of approximately 750,758 dwt.